Follow on Google News News By Tag * Baybio * Bio Supply Management Alliance * Supply Chain Management * Biotech Supply Chain Academy * Executives * Education * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() Bio Supply Management Alliance and Baybio Forge Strategic Relationship to Advance Supply ChainSignificant advances will be achieved in the supply chain of the biopharma industry by leveraging the synergies of Baybio and the Biotech Supply Chain Academy, the premiere event for supply management professionals to be held October 26.
By: Tim Salaver, Bio Supply Management Alliance The conference titled “TRANSFORMING THE GLOBAL SUPPLY CHAIN FOR END-TO-END VISIBILITY & QUALITY PATIENT CARE", will provide an exclusive audience of senior-level executives of the biopharma industry with authoritative insights, best practices and market intelligence about the supply and distribution of biotechnology products. Eminent industry executives and academia will present their initiatives in the areas of supply chain management, risk management, talent development, strategic sourcing, information technology network and cold chain. According to Devendra Mishra, BSMA Executive Director and Pepperdine University adjunct professor, “Significant advances will be achieved in the supply chain of the biopharma industry by leveraging the synergies of Baybio and the Biotech Supply Chain Academy in Northern California, the birthplace of the biotech industry. Baybio’s advocacy, enterprise support and enhancement of research collaboration are a powerful and complimentary enabler in ensuring end-to-end development of technology, business processes and collaborative relationships for enhanced patient care.” “BayBio works to provide its members opportunities to improve their capital efficiency, and supply chain management is key,” said Gail Maderis, President and CEO, Baybio. “We encourage BayBio members to explore opportunities to reduce operating cost and risk while maximizing patient care through creative supply chain management.” The focus of the conference will be the Top 10 supply chain issues facing the biotech industry: • Gartner Research of “The AMR Research Healthcare Top 25” • Optimization of Risk in the End-to-end Supply Chain: The best practices for the identification, measurement, and execution of managing risks in the industry • Global Healthcare Exchange and Distribution Services to Hospitals • Development of Supply Chain Talent Management: Learnings from the Best of the Breed from other Industries and Academia • Information Technology Management: The Holy Grail! Proven solutions from procure to pay to ePedigree and visibility in the Supply Chain • Global Strategic Sourcing: Sourcing Development Strategies in a Collaborative Environment to Maximize Supplier and Vendor Relationships. • Track and Trace and Preparation for ePedigree Legislation in 2015 • Working Capital Management: Ensuring the Financial Bottom Line of SCM • CRO, CMO, R&D and Business Analytics Services: The New Outsourcing Frontiers! • Cold Chain & Logistics Management: Technologies, Standards, Best of the Breed Case studies and Training # # # About Bio Supply Management Alliance (BSMA) The BSMA is a worldwide community of operations and supply chain management leaders and professionals in the biopharma industries. The Alliance provides a collaborative forum for learning and best practice sharing of practitioners, executives and thought leaders in this uniquely demanding industry sector. About Baybio It is an independent, non-profit 501(c)(6) trade association serving the life science industry through representatives in South San Francisco and through coalition partners in Washington, DC. Through advocacy, membership services, programs and more, Baybio brings the world's greatest life science community to your fingertips. The Mission of Baybio is to support the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Our members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. End
|
|